用局部多贝斯酸清除脂溢性角化病。
Clearance of seborrhoeic keratoses with topical dobesilate.
作者信息
Cuevas Pedro, Angulo Javier, Salgüero Irene, Giménez-Gallego Guillermo
机构信息
Departamento de Investigación, Servicio de Histología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
出版信息
BMJ Case Rep. 2012 Jun 21;2012:bcr0120125628. doi: 10.1136/bcr.01.2012.5628.
Abstract
A patient with two seborrhoeic keratoses in the face received a single daily application of dobesilate cream during 6 months. Dobesilate achieved complete clearance of the seborrhoeic keratosis lesions with good cosmoses, suggesting that this compound is a safe and efficient candidate in the treatment of seborrhoeic keratoses.
摘要
一名面部有两个脂溢性角化病的患者在6个月内每天涂抹一次多贝斯乳膏。多贝斯使脂溢性角化病皮损完全消退，且外观良好，这表明该化合物是治疗脂溢性角化病的一种安全有效的选择。
相似文献
1
Clearance of seborrhoeic keratoses with topical dobesilate.用局部多贝斯酸清除脂溢性角化病。
BMJ Case Rep. 2012 Jun 21;2012:bcr0120125628. doi: 10.1136/bcr.01.2012.5628.
2
Topical treatment of actinic keratoses with potassium dobesilate 5% cream. a preliminary open-label study.5%卡泊三醇乳膏外用治疗光化性角化病的初步开放性研究。
Eur J Med Res. 2011 Feb 24;16(2):67-70. doi: 10.1186/2047-783x-16-2-67.
3
Hydrogen Peroxide Topical Solution, 40% (w/w) for the Treatment of Seborrheic Keratoses: A Review.40%（重量/重量）过氧化氢外用溶液治疗脂溢性角化病：综述
Skin Therapy Lett. 2020 Jan;25(1):1-4.
4
Topical calcipotriol is not effective in facial seborrhoeic dermatitis.
J Dermatolog Treat. 2001 Sep;12(3):179. doi: 10.1080/09546630152608339.
5
Treatment of facial actinic keratoses with a cream containing octatrienoic acid: a multicenter clinical experience.用含十八碳三烯酸的乳膏治疗面部光化性角化病：一项多中心临床经验。
G Ital Dermatol Venereol. 2018 Dec;153(6):860-865. doi: 10.23736/S0392-0488.18.06064-9. Epub 2018 Jun 29.
6
Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review.脂溢性角化病局部治疗的疗效与安全性：一项系统评价
J Dermatolog Treat. 2023 Dec;34(1):2133532. doi: 10.1080/09546634.2022.2133532. Epub 2022 Nov 13.
7
Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.
Br J Dermatol. 1987 Feb;116(2):217-21. doi: 10.1111/j.1365-2133.1987.tb05815.x.
8
A novel topical agent in the treatment of seborrheic keratoses: A proof of concept study by clinical and dermoscopic evaluation.一种治疗脂溢性角化病的新型局部治疗药物：临床和皮肤镜评估的概念验证研究。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12526. Epub 2017 Aug 10.
9
Unusual clinical manifestation of seborrheic keratosis on the scalp successfully treated with topical trichloroacetic acid: an atypical case report.头皮脂溢性角化病的不典型临床表现，经局部三氯乙酸治疗成功：一例不典型病例报告。
Pan Afr Med J. 2020 Sep 28;37:98. doi: 10.11604/pamj.2020.37.98.26090. eCollection 2020.
10
Ivermectin 1% Cream (Soolantra) for Inflammatory Lesions of Rosacea.
Am Fam Physician. 2016 Sep 15;94(6):512-3.
引用本文的文献
1
An exophytic and symptomatic lesion of the labial mucosa diagnosed as labial seborrheic keratosis.唇部黏膜的外生性有症状病变，诊断为唇部脂溢性角化病。
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2749-2752. eCollection 2019.
2
Patient Preferences and Comparative Outcomes Regarding Cryosurgery versus Electrodesiccation in the Removal of Truncal Seborrheic Keratoses.关于冷冻手术与电干燥法去除躯干脂溢性角化病的患者偏好及比较结果
J Clin Aesthet Dermatol. 2019 Sep;12(9):E53-E56. Epub 2019 Sep 1.
3
Recent advances in managing and understanding seborrheic keratosis.脂溢性角化病管理与认识的最新进展
F1000Res. 2019 Aug 28;8. doi: 10.12688/f1000research.18983.1. eCollection 2019.
4
Seborrheic Keratoses - The Most Common Benign Skin Tumor of Humans. Clinical presentation and an update on pathogenesis and treatment options.脂溢性角化病——人类最常见的良性皮肤肿瘤。临床表现及发病机制与治疗选择的最新进展。
Open Access Maced J Med Sci. 2018 Nov 23;6(11):2270-2275. doi: 10.3889/oamjms.2018.460. eCollection 2018 Nov 25.
5
Diclofenac gel may be a new treatment option for seborrheic keratosis.双氯芬酸凝胶可能是脂溢性角化病的一种新的治疗选择。
Indian Dermatol Online J. 2016 May-Jun;7(3):211-2. doi: 10.4103/2229-5178.182363.
本文引用的文献
1
Topical treatment of contact dermatitis by pine processionary caterpillar.松毒蛾对接触性皮炎的局部治疗
BMJ Case Rep. 2011 Aug 11;2011:bcr0620114351. doi: 10.1136/bcr.06.2011.4351.
2
Efficacy of the fibroblast growth factor inhibitor 2,5-dihydroxyphenylsulfonate in basal cell carcinoma: a histopathological and inmunohistochemical study.成纤维细胞生长因子抑制剂 2,5-二羟基苯磺酸酯治疗基底细胞癌的疗效：一项组织病理学和免疫组织化学研究。
J Dermatolog Treat. 2011 Dec;22(6):348-52. doi: 10.3109/09546634.2010.551108. Epub 2011 Jul 14.
3
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.龙胆酸是一种与植物防御有关的化合物，也是阿司匹林的一种代谢物，它是一类新型的体内成纤维细胞生长因子抑制剂。
J Biol Chem. 2010 Apr 9;285(15):11714-29. doi: 10.1074/jbc.M109.064618. Epub 2010 Feb 9.
4
Seborrheic keratosis.脂溢性角化病。
J Dtsch Dermatol Ges. 2008 Aug;6(8):664-77. doi: 10.1111/j.1610-0387.2008.06788.x.
5
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.体细胞性成纤维细胞生长因子受体3（FGFR3）和磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α（PIK3CA）突变存在于家族性脂溢性角化病中。
Br J Dermatol. 2008 Jul;159(1):214-7. doi: 10.1111/j.1365-2133.2008.08626.x. Epub 2008 Jul 1.
6
Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern.致癌性PIK3CA突变发生于具有特征性突变模式的表皮痣和脂溢性角化病中。
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13450-4. doi: 10.1073/pnas.0705218104. Epub 2007 Aug 2.
7
Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses.多个个体内脂溢性角化病中FGFR3突变的谱系
J Invest Dermatol. 2007 Aug;127(8):1883-5. doi: 10.1038/sj.jid.5700804. Epub 2007 Mar 29.
8
Therapeutic response of rosacea to dobesilate.酒渣鼻对羟苯磺酸钙的治疗反应。
Eur J Med Res. 2005 Oct 18;10(10):454-6.
9
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.三元成纤维细胞生长因子-成纤维细胞生长因子受体-肝素复合物的晶体结构揭示了肝素在成纤维细胞生长因子受体结合和二聚化中的双重作用。
Mol Cell. 2000 Sep;6(3):743-50. doi: 10.1016/s1097-2765(00)00073-3.
Zotero 插件